- 301. Fetal malnutrition without mention of "light-for-dates", unspecified [weight]
- [ ] (UMLS (ICD9CM) C0158872) =Disease or Syndrome
| - 327. fetus chemotherapy
- [ ] (UMLS (CSP) C0920743) =Therapeutic or Preventive Procedure ;
|
- 302. fetal monitoring
- [Physiologic or biochemical monitoring of the fetus. It is usually done during LABOR, OBSTETRIC and may be performed in conjunction with the monitoring of uterine activity. It may also be performed prenatally as when the mother is undergoing surgery. ( MSH )] (UMLS (CSP) C0015945) =Diagnostic Procedure
| - 328. fetus circulation
- [ ] (UMLS (CSP) C0920516) =Organ or Tissue Function
|
- 303. fetal neoplasm
- [ ] (UMLS (CSP) C0598366) =Neoplastic Process ;
| - 329. fetus culture
- [ ] (UMLS (CSP) C0920517) =Research Activity
|
- 304. fetal nutrition
- [ ] (UMLS (CSP) C0598900) =Organism Attribute ;
| - 330. fetus drug adverse effect
- [ ] (UMLS (CSP) C0920518) =Injury or Poisoning
|
- 305. FETAL OPS-FACILITATE DEL
- (UMLS (ICD9CM) C0846357) Operations on fetus to facilitate delivery;
=Therapeutic or Preventive Procedure | - 331. fetus growth disorder
- [ ] (UMLS (CSP) C0920519) =Disease or Syndrome
|
- 306. fetal protein
- [ ] (UMLS (CSP) C0015950) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 332. fetus membrane
- [Extra-embryonic tissues that contain the FETUS during PREGNANCY. They provide the support to accommodate FETAL DEVELOPMENT. Depending on the species, their structure and complexity vary greatly in the different forms of PLACENTA. These membranes undergo rupture during PARTURITION. ( MSH )] (UMLS (CSP) C0015943) =Embryonic Structure ;
|
- 307. FETAL PULSE OXIMETRY
- [ ] (UMLS (ICD9CM) C0994541) =Diagnostic Procedure
| - 333. Fetus or newborn affected by complications of placenta, cord, and membranes
- [ ] (UMLS (ICD9CM) C0270025) =Pathologic Function
|
- 308. Fetal Rhabdomyoma
- [A rare benign mesenchymal neoplasm arising from skeletal muscle. It is characterized by the presence of immature spindle and polygonal cells within a scant myxoid stroma. It usually develops in the head and neck region of young children. ( NCI )] (UMLS (NCI) C0334482) =Neoplastic Process
| - 334. Fetus or newborn affected by maternal complications of pregnancy
- [ ] (UMLS (ICD9CM) C0158816) =Disease or Syndrome
|
- 309. fetal rickets
- [ ] (UMLS (CSP) C0242080) =Disease or Syndrome
| - 335. Fetus or newborn affected by maternal conditions which may be unrelated to present pregnancy
- [ ] (UMLS (ICD9CM) C0158799) =Disease or Syndrome
|
- 310. fetal stress
- [ ] (UMLS (CSP) C0456057) =Pathologic Function =stress;
| - 336. Fetus or newborn affected by other complications of labor and delivery
- [ ] (UMLS (ICD9CM) C0473833) =Disease or Syndrome ;
|
- 311. fetal surgery
- [ ] (UMLS (CSP) C1261465) fetus surgery;
=Therapeutic or Preventive Procedure ;
| - 337. fetus pharmacology
- [ ] (UMLS (CSP) C0920520) =Biomedical Occupation or Discipline
|
- 312. fetal tissue
- [Any tissue from a fetus. ( NCI )] (UMLS (CSP) C0242291) =Tissue
| - 338. fetus pharmacotherapy
- [ ] (UMLS (CSP) C1328879) =Therapeutic or Preventive Procedure ;
|
- 313. fetal tissue transplantation
- [Transference of fetal tissue between individuals of the same species or between individuals of different species. ( MSH )] (UMLS (CSP) C0079345) =Therapeutic or Preventive Procedure ;
| - 339. fetus preservation
- [ ] (UMLS (CSP) C0920521) =Laboratory Procedure
|
- 314. FETAL-MATERN HEM-ANTEPAR
- [ ] (UMLS (ICD9CM) C0157104) =Disease or Syndrome
| - 340. fetus therapy
- [Prenatal interventions to correct fetal anomalies or treat FETAL DISEASES in utero. Fetal therapies include several major areas, such as open surgery; FETOSCOPY; pharmacological therapy; INTRAUTERINE TRANSFUSION; STEM CELL TRANSPLANTATION; and GENE THERAPY. ( MSH )] (UMLS (CSP) C0015952) =Therapeutic or Preventive Procedure
|
- 315. FETAL-MATERNAL HEM-DELIV
- [ ] (UMLS (ICD9CM) C0157103) =Disease or Syndrome
| - 341. fetus toxicology
- [ ] (UMLS (CSP) C0920522) =Biologic Function
|
- 316. Fetal-maternal hemorrhage affecting management of mother
- [ ] (UMLS (ICD9CM) C0157101) =Disease or Syndrome
| - 342. fetus transplantation
- [ ] (UMLS (CSP) C0920523) =Therapeutic or Preventive Procedure
|
- 317. Fetal-maternal hemorrhage, unspecified as to episode of care in pregnancy
- [Transplacental passage of fetal blood into the circulation of the maternal organism. (Dorland, 27th ed) ( MSH )] (UMLS (ICD9CM) C0015959) =Pathologic Function =Anemia, Neonatal;
| - 343. FEV increased
- [An increase in the fraction of the forced vital capacity that is exhaled in a specific number of seconds. ( NCI )] (UMLS (NCI) C0520836) =Finding
|
- 318. FETAL/NEONATAL HEPATITIS
- [ ] (UMLS (ICD9CM) C0158976) =Disease or Syndrome ;
| - 344. FEV1
- [A test of lung function, the FEV1 is the volume exhaled during the first second of a forced expiratory maneuver started from the level of total lung capacity. It is the most frequently used index for assessing bronchoconstriction or bronchodilatation. ( NCI )] (UMLS (NCI) C0849974) FEV1%VC;
Forced Expiratory Volume 1 Test;
Forced Expiratory Volume in 1 Second;
PFT/FEV1;
Pulmonary Function Test/Forced Expiratory Volume 1;
=Diagnostic Procedure |
- 319. FETAL/NEONATAL JAUND NOS
- [ ] (UMLS (ICD9CM) C0270206) =Disease or Syndrome
| - 345. Fever
- [abnormal elevation of body temperature, usually as a result of a pathologic process.(CSP)] (UMLS (ICPC) C0015967) (Fever; SUKARRA; Feber; Koorts; KUUME; Fievre; Fieber; xom; laz; Febbre; FEBER; Febre; Fiebre; FEBER) =Finding =body temperature; Body Temperature Changes; Clinical Finding; GENERAL AND UNSPECIFIED; Symptoms and Complaints Component; =Febrile convulsions (simple), unspecified; anesthesia related hyperthermia; Fever of Unknown Origin; Sweating Sickness;
|
- 320. FETISHISM
- [A condition in which inanimate objects are utilized as a preferred or exclusive method of stimulating erotic arousal. ( MSH )] (UMLS (ICD9CM) C0015957) =Mental or Behavioral Dysfunction =Paraphilias;
| - 346. Fever Chills
- (UMLS (NCI) C0085594) =Sign or Symptom
|
- 321. fetomaternal circulation
- [vessels, supply, and flow of blood propelled through the umbilical vessels (allantoic), intervillous space (intervillous), placenta, chorionic villi and the fetal heart. ( CSP )] (UMLS (CSP) C0597280) =Organ or Tissue Function ;
=reproductive system circulation;
=umbilical cord;
Blood, Cord;
placental transfer;
| - 347. Fever of Unknown Origin
- [Fever in which the etiology cannot be ascertained. ( MSH )] (UMLS (NCI) C0015970) =Sign or Symptom =Febbre;
|
- 322. FETOPEL DISPROP-ANTEPART
- (UMLS (ICD9CM) C1142292) Fetopelvic disproportion, antepartum =Disease or Syndrome
| - 348. Few
- (UMLS (NCI) C0205388) =Quantitative Concept
|
- 323. FETOPELV DISPROP-UNSPEC
- (UMLS (ICD9CM) C1142293) Fetopelvic disproportion, unspecified as to episode of care =Disease or Syndrome
| - 349. Fexinidazole
- (UMLS (NCI) C0060304) =Organic Chemical; Pharmacologic Substance ;
|
- 324. FETOPELV DISPROPOR-DELIV
- [ ] (UMLS (ICD9CM) C0156982) =Disease or Syndrome ;
| - 350. FEXOFENADINE
- [A second generation, long-lasting selective histamine H1 receptor antagonist with antiinflammatory property. Fexofenadine is a highly selective and reversible competitor at peripheral H1 histamine receptors in the gastrointestinal (GI) tract, blood vessels, and bronchial smooth muscle. This agent interferes with mediators release from mast cells either by inhibiting calcium ion influx across mast cell/basophil plasma membrane or by inhibiting intracellular calcium ion release within the cells. In addition fexofenadine may also inhibit the late-phase allergic reaction by acting on leukotrienes or prostaglandins, or by producing an anti-platelet activating factor effect. Overall, this agent blocks the actions of endogenous histamine, thereby leads to temporary relief of the negative symptoms associated with histamine and achieve effects such as decreased vascular permeability, reduction of pruritus and localized smooth muscle relaxation. ( NCI )] (UMLS (NCI) C0296800) =Organic Chemical; Pharmacologic Substance ;
=Terfenadine;
[AH600] ANTIHISTAMINES, BUTYROPHENONE =Fexofenadine HCl |
- 325. Fetopelvic disproportion
- [A condition in which the HEAD of the FETUS is larger than the mother's PELVIS through which the fetal head must pass during a vaginal delivery. ( MSH )] (UMLS (ICD9CM) C0085988) =Finding
| - 351. Fexofenadine HCl
- [The hydrochloride salt form of fexofenadine, a carboxylated metabolic derivative of terfenadine and third generation selective histamine H1-receptor antagonist with antihistaminic and non-sedative effects. Fexofenadine competitively binds peripheral H1-receptors, thereby stabilizing an inactive conformation of the receptor. Consequently histamine binding and activity as a result of mast-cell degranulation followed by the release of multiple inflammatory mediators, such as interleukins, prostaglandin and leukotriene precursors, is blocked, thereby preventing the triggering of pro-inflammatory pathways. ( NCI )] (UMLS (NCI) C0771752) Fexofenadine Hydrochloride;
FEXOFENADINE HYDROCHLORIDE PREPARATION;
=Organic Chemical; Pharmacologic Substance =FEXOFENADINE;
=FEXOFENADINE HYDROCHLORIDE 60 MG;
FEXOFENADINE HYDROCHLORIDE 180 MG;
FEXOFENADINE HYDROCHLORIDE 30 MG |
- 326. fetus cell
- [ ] (UMLS (CSP) C0920514) =Embryonic Structure
| |
home
